|Bid||2.0500 x 1100|
|Ask||2.0900 x 4000|
|Day's Range||1.9300 - 2.1900|
|52 Week Range||1.1500 - 124.0000|
|Beta (5Y Monthly)||2.09|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||210.00|
Tivic Health Systems, Inc. (TIVC) delivered earnings and revenue surprises of 78.86% and 63.85%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
SAN FRANCISCO, November 14, 2023--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced its financial results for the third quarter 2023 ended September 30, 2023 ("Q3 2023").
InvestorsObserver issues critical PriceWatch Alerts for TIVC, TYGO, TATT, PSTV, and ABOS.